Creating and Managing a Drug Formulary

On this episode, we are joined by Dr. Nina Lathia, BScPhm, RPh, MSc, PhD, to discuss the process of developing and managing a drug formulary. Dr. Lathia is a pharmacist and health economist in Toronto, Canada. She defines a drug formulary and explains some of the criteria used to establish a specific formulary. She also reviews some of the following:  - Comparative effectiveness studies including clinical trials, and real-world studies including a discussion of pros and cons of RCTs vs. real-world studies - Using the PICO (population, intervention, comparator, outcomes) framework to evaluate studies; - Types of studies that best inform safety outcomes (adverse events) - Economic studies – a brief overview of cost-effectiveness analysis - Principles of fair access to prescription drugs - Challenges that prescribers and clinicians experience when trying to navigate formularies You can contact Dr. Lathia at the following e-mail address or at her LinkedIn profile: [email protected] LI profile: https://www.linkedin.com/in/ninalathia/   If you want some handouts on study design from Dr. Lathia, click the link below: Study Design Review   Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - [email protected] Cole - [email protected] Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

There are no comments yet.

Please log in to write the first comment.